• Shdwdrgn@mander.xyz
    link
    fedilink
    English
    arrow-up
    2
    ·
    7 months ago

    “We managed to not kill the first subject, but we’re hopeful to succeed in the future”…

      • Zedstrian@lemmy.dbzer0.com
        link
        fedilink
        English
        arrow-up
        2
        ·
        edit-2
        7 months ago

        A success does not include leaving a victim of failed experimental medicine with a non-functional implant. In contrast to how animal subjects are used as test subjects (often conducted with less oversight than there should be), using experimental medicine on volunteering patients should be done not just to collect better data than the chimps before them supplied, but with the genuine expectation that the product in question will benefit the patient beyond their usefulness as a test subject for continued product development.

        • FaceDeer@fedia.io
          link
          fedilink
          arrow-up
          0
          arrow-down
          1
          ·
          7 months ago

          SpaceX has a 64% market share in the global commercial rocket launch market for sending satellites, scientific instruments, and other payloads into orbit. In the first six months of 2023, SpaceX handled 21 flights for outside customers, or 64% of the worldwide total. In the first half of 2023, SpaceX handled 88 percent of customer flights from U.S. launch sites.[1]

          If success isn’t their goal I’d be amazed at what they accomplished if the decided to try for it someday.